This standardized dermatological procedure identifies allergic contact dermatitis. It involves applying a series of common allergens, typically eighty, to the skin under occlusive patches for a defined period, usually 48 hours. The patches are then removed, and the skin is assessed for reactions. A positive reaction indicates sensitivity to a specific substance, revealing potential causes of skin irritation or allergic responses. For example, a patient experiencing persistent eczema may undergo this evaluation to pinpoint environmental or product-related allergens contributing to their condition.
The examination plays a vital role in diagnosing and managing allergic contact dermatitis, thereby improving patients’ quality of life by allowing them to avoid identified allergens. Historically, this type of testing has evolved from simpler methods involving fewer substances to the current comprehensive panel, reflecting increased understanding of prevalent allergens and refinement of diagnostic techniques. The benefit of using a standardized panel is that it allows dermatologists across North America to compare results and share best practices.
